These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22950447)

  • 21. Omega-3 Fatty Acids in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
    Garcia JM; Shamliyan TA
    Am J Med; 2017 Oct; 130(10):1151-1155. PubMed ID: 29016347
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
    Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anorexia and cachexia in advanced cancer patients.
    Vigano A; Watanabe S; Bruera E
    Cancer Surv; 1994; 21():99-115. PubMed ID: 8565002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials referral resource. Cancer chemoprevention and control trials.
    Brawley OW; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Apr; 10(4):499-500. PubMed ID: 8723279
    [No Abstract]   [Full Text] [Related]  

  • 25. Toward a treatment for anorexia and cachexia in patients with cancer.
    Thirlby RC
    Gastroenterology; 1991 Jul; 101(1):268-70. PubMed ID: 2044918
    [No Abstract]   [Full Text] [Related]  

  • 26. Anorexia and cachexia.
    Enck RE
    Am J Hosp Care; 1987; 4(5):13-5. PubMed ID: 3476126
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer control research in the North Central Cancer Treatment Group (NCCTG).
    Loprinzi CL; Miser AW; Kardinal C; Everson LK; Ahlquist DA; Dose AM; Moertel CG
    Prog Clin Biol Res; 1989; 293():345-53. PubMed ID: 2657773
    [No Abstract]   [Full Text] [Related]  

  • 28. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Graf SA; Garcia JM
    Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
    Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
    J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological therapy of cancer anorexia-cachexia].
    Cardona D
    Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.
    Choi YK; Jung KY; Woo SM; Yun YJ; Jun CY; Park JH; Shin YC; Cho SG; Ko SG
    Mediators Inflamm; 2014; 2014():736563. PubMed ID: 24963216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated anorexia and cachexia. Implications for drug therapy.
    Loprinzi CL; Goldberg RM; Burnham NL
    Drugs; 1992 Apr; 43(4):499-506. PubMed ID: 1377116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalidomide in the treatment of cancer cachexia.
    Tassinari D; Santelmo C; Tombesi P; Sartori S
    J Palliat Care; 2008; 24(3):187-9. PubMed ID: 18942570
    [No Abstract]   [Full Text] [Related]  

  • 36. North Central Cancer Treatment Group (NCCTG).
    Loprinzi CL
    J Natl Cancer Inst Monogr; 1996; (20):79-80. PubMed ID: 8750472
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.
    Reuter SE; Martin JH
    Clin Pharmacokinet; 2016 Jul; 55(7):807-812. PubMed ID: 26883879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients].
    Nauck F; Klaschik E
    Schmerz; 2004 Jun; 18(3):197-202. PubMed ID: 15221423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
    Cabeza C; Corsi O; Pérez-Cruz P
    Medwave; 2017 Dec; 17(9):e7130. PubMed ID: 29286357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of herbal medicines for the treatment of cancer cachexia in animal models.
    Park B; You S; Cho WCS; Choi JY; Lee MS
    J Zhejiang Univ Sci B; 2019 Jan.; 20(1):9-22. PubMed ID: 30614226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.